FIELD: medicine.
SUBSTANCE: according to the present invention, there are disclosed disease diagnostic techniques and sets characterised by nonphysiological content of protein Hepsidin in mammals. Substance of the invention lies in binding antibody and polypeptide, where antibody or its fragment is specifically bound with one or more average epitopes or epitopes of carboxyl termination of sequence SEQ ID NO: 2. Additionally, there are disclosed relevant antibodies.
EFFECT: disease screening characterised by nonphysiological content of protein Hepsidin in organism.
19 cl, 2 ex, 16 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-HEPCIDIN ANTIBODIES AND USES THEREOF | 2014 |
|
RU2668391C2 |
| METHODS FOR TREATMENT OF DISEASE, USING BONE MORPHOGENETIC PROTEIN 6 (BMP6) INHIBITORS | 2017 |
|
RU2790023C2 |
| APPLICATION OF HEAT-SHOCK PROTEINS FOR IMPROVING EFFECTIVENESS OF ANTIBODY THERAPIES | 2003 |
|
RU2375077C2 |
| METHOD OF TUMOUR TREATMENT IN SUBJECT | 2006 |
|
RU2404193C2 |
| ANGIOGENESIS INHIBITION | 2008 |
|
RU2471498C2 |
| INHIBITION OF DISSEMINATION OF TUMOUR USING Bv8 OR G-CSF ANTAGONISTS | 2010 |
|
RU2567803C2 |
| POLYPEPTIDE WITH ANTIVIRAL ACTIVITY, ITS PRODUCTION AND USE | 2004 |
|
RU2372356C2 |
| SPECIFIC BINDING PROTEINS AND APPLICATIONS THEREOF | 2010 |
|
RU2549678C2 |
| HOMOGENOUS PREPARATIONS OF IL-28 AND IL-29 | 2004 |
|
RU2518324C2 |
| APPLICATION OF PAK INHIBITOR FOR ARTHROPATHY TREATMENT | 2004 |
|
RU2360696C2 |
